rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Globus Medical, Inc.

GMED · NYSE

Health CareMedical DevicesNot moving yetRobotics

GMED stood above a rising 150-day average in 24 of the last 52 weekly readings, and has been out of that trend for the last 24 weeks. It is 6.3% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 24
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$27.3M
Officials’ trades on record
29
Institutions holding
560 (-5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 24 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$20.1M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

29 disclosed lines: House 28, Senate 1, executive 0; 9 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k3 Sep 2026filed 12 Oct 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$15k–$50k19 Aug 2026filed 10 Sep 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k3 Mar 2026filed 7 Apr 2026
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k10 Jul 2025filed 13 Aug 2025
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k24 Jun 2025filed 13 Aug 2025
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k17 Jun 2025filed 13 Aug 2025
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k9 Apr 2025filed 14 May 2025
Josh Gottheimer House: U.S. House ClerkNJ05boughtjoint$1k–$15k3 Apr 2023filed 19 May 2023
Daniel S. Goldman House: U.S. House ClerkNY10sold$15k–$50k6 Mar 2023filed 17 Apr 2023
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k8 Feb 2023filed 17 Mar 2023
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k11 Jan 2023filed 17 Feb 2023
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39sold$1k–$15k1 Jun 2020filed 16 Jun 2020

Insiders

Buy orders, 12 months0
Sale orders, 12 months14
Buyers · sellers0 · 7
WhoDidSharesTraded
James R. TobinDirectorsold30,000at $74.5815 Sep 2026filed 16 Sep 2026
Stephen T. ZarrilliDirectorsold25,000at $87.0418 Aug 2026filed 19 Aug 2026
David D. DavidarDirectorsold25,000at $80.765 Jun 2026filed 9 Jun 2026
Kelly HullerEVP, GC, Corporate Secretarysold20,000at $94.5025 Feb 2026filed 27 Feb 2026
Kelly HullerEVP, GC, Corporate Secretarysold10,000at $87.6712 Feb 2026filed 17 Feb 2026
Leslie V. NorwalkDirectorsold2,000at $101.108 Jan 2026filed 12 Jan 2026
Kyle KlineSenior Vice President, CFOsold3,594at $101.108 Jan 2026filed 12 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders560-5 on the quarter
New · exited82 · 88
Reported value$9.2B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202610,806,724$853.8M+309,310+2.9%
Jupiter Topco LLCnew · filed 14 Aug 20268,200,423$647.9M+8,200,423
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20265,107,532$403.5M+74,800+1.5%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20264,994,385$394.6M+114,926+2.4%
Invesco Ltd.reduced · filed 14 Aug 20264,309,771$340.5M-6,883−0.2%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLCnew · filed 13 Aug 20264,279,730$338.1M+4,279,730
STATE STREET CORPadded · filed 7 Aug 20263,714,029$293.5M+123,657+3.4%
Sculptor Capital LPreduced · filed 14 Aug 20263,000,000$237.0M-58,000−1.9%
JPMORGAN CHASE & COnew · filed 12 Aug 20262,743,850$230.8M+2,743,850
BANK OF MONTREALadded · filed 12 Aug 20262,425,491$191.6M+118,310+5.1%
31 Mar 2023 – 30 Jun 2026
324440556Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

James R. Tobin Company insiderDirector · last 15 Sep 20260 · 9
Gilbert Ray Cisneros, Jr. HouseCA31 · last 3 Sep 20264 · 3
Stephen T. Zarrilli Company insiderDirector · last 18 Aug 20260 · 2
David D. Davidar Company insiderDirector · last 27 Jul 20260 · 25
Ann D. Rhoads Company insiderDirector · last 4 Jun 20260 · 5
Kelly Huller Company insiderEVP, GC, Corporate Secretary · last 25 Feb 20260 · 17
Dan Lemaitre Company insiderDirector · last 21 Jan 20260 · 5
Dan Wolterman Company insiderDirector · last 21 Jan 20260 · 0
David C. Paul Company insiderExecutive Chairman · last 21 Jan 20260 · 9
John A. DeFord Company insiderDirector · last 21 Jan 20260 · 0
Keith W. Pfeil Company insiderPresident, CEO · last 21 Jan 20260 · 9
Kyle Kline Company insiderSenior Vice President, CFO · last 21 Jan 20260 · 2

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202567.4%
Operating profit marginFY 2025 · to 31 Dec 202516.3%
Free cash flow marginFY 2025 · to 31 Dec 202520.0%
Return on capital employedFY 2025 · to 31 Dec 202510.0%
Cash conversionFY 2025 · to 31 Dec 2025140%
Research spendFY 2025 · to 31 Dec 20255.0%
Share count trendFY 2025 · to 20 Feb 2026-1.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$526.2M
Free cash flowFY 2025 · to 31 Dec 2025$588.8M

Analyst forecasts

No analyst forecasts yet.